A panel of physicians, biotech leaders and patient advocates took aim at the FDA during a Senate hearing on how the agency’s bureaucracy affects innovation. More: 'Like talking to a brick wall': Senate hearing takes aim at FDA's rare disease
read moreFollowing an unexpected delay of the CDC vaccine panel’s February meeting, the Advisory Committee on Immunization Practices (ACIP) has selected dates next month to convene and discuss, among other matters, COVID-19 vaccine safety. More: After delay, CDC vaccine panel sets
read moreAlready on a roll with its first-in-class FcRn blocker Vyvgart, argenx has reported successful trial results that could pave the way for the fast-rising blockbuster to reach a new indication—ocular myasthenia gravis. More: OMG—argenx scores again with Vyvgart in ocular
read moreWith a new online resource, Eisai is offering patients and caregivers some direction to help navigate a kidney cancer diagnosis. More: Eisai points the way to kidney cancer support with Kompass digital hub Source: fierce
read more
Phase 2 study reports significantly accelerated debridement and wound repair in venous leg ulcers More: SolasCure trial shows faster healing with Aurase Wound Gel Source: News
read more
New phase 3 results highlight potential alternative for adults switching from complex regimens More: Gilead data show investigational HIV combination maintains viral suppression Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals